We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

75 hedge funds and large institutions have $68.1M invested in IVERIC bio, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

59% more call options, than puts

Call options by funds: $275K | Put options by funds: $173K

12% more funds holding

Funds holding: 67 → 75 (+8)

8% more capital invested

Capital invested by funds: $63.3M → $68.1M (+$4.76M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

22% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 23

Holders
75
Holders Change
+8
Holders Change %
+11.94%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
18
Reduced
23
Closed
9
Calls
$275K
Puts
$173K
Net Calls
+$102K
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.36M
2
AL
AJO LP
Pennsylvania
+$2.05M
3
OAM
Oxford Asset Management
United Kingdom
+$1.24M
4
Millennium Management
Millennium Management
New York
+$955K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$831K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$3.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$2.54M
3
BlackRock
BlackRock
New York
-$1.54M
4
LCM
Laurion Capital Management
New York
-$1.21M
5
First Manhattan
First Manhattan
New York
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
ROTUOC
51
Regents of the University of California
California
$50K – – –
BCM
52
Bayesian Capital Management
New York
$49K +$44.3K +15,756 New
DTL
53
Dynamic Technology Lab
Singapore
$40K +$36.1K +12,854 New
CAN
54
Cetera Advisor Networks
California
$35K – – –
Squarepoint
55
Squarepoint
New York
$31K -$151K -53,800 -84%
TDC
56
Thompson Davis & Co
Virginia
$26K +$23.1K +8,225 New
HCM
57
Highlander Capital Management
New Jersey
$19K – – –
CG
58
Cutler Group
California
$17K -$98 -35 -0.6%
Public Employees Retirement Association of Colorado
59
Public Employees Retirement Association of Colorado
Colorado
$16K – – –
MAM
60
Meeder Asset Management
Ohio
$7K -$10.7K -3,800 -64%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$6K +$76 +27 +1%
UBS Group
62
UBS Group
Switzerland
$6K +$3.43K +1,219 +167%
EWM
63
Endurance Wealth Management
Rhode Island
$5K – – –
TRCT
64
Tower Research Capital (TRC)
New York
$4K -$2.28K -810 -39%
FDCDDQ
65
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.44K – – –
Bank of America
66
Bank of America
North Carolina
$2K -$33.4K -11,884 -96%
Citigroup
67
Citigroup
New York
$2K -$5.34K -1,900 -73%
AP
68
Atwood & Palmer
Missouri
$2K – – –
FANJ
69
Financial Architects (New Jersey)
New Jersey
$1K – – –
LTFS
70
Ladenburg Thalmann Financial Services
Florida
$1K – – –
STA
71
Summit Trail Advisors
New York
$1K +$942 +335 New
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$187 – – –
APA
73
American Portfolios Advisors
New York
$156 +$141 +50 New
LCM
74
Laurion Capital Management
New York
– -$1.21M -427,472 Closed
First Manhattan
75
First Manhattan
New York
– -$1.2M -426,144 Closed
1 2
3
4

ISEE Hedge Fund Activity: Q4 2017 in Review

75 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2017, worth a combined $68.1M — up 7.5% from $63.3M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ISEE positions and 9 closed out — a net gain of 9 holders — while 18 added to existing stakes and 23 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.36M. The largest seller was Stonepine Capital Management, cutting an estimated $3.2M.

  • 75 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2017, up from 67 in Q3 2017.
  • Funds reported $68.1M of IVERIC bio, Inc. Common Stock stock for Q4 2017, up 7.5% quarter-over-quarter.
  • 18 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2017 and 9 closed out, a net change of +9 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q4 2017 was Morgan Stanley, an estimated $2.36M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q4 2017 was Stonepine Capital Management, an estimated $3.2M sold.

Based on aggregated 13F filings for Q4 2017.